[go: up one dir, main page]
More Web Proxy on the site http://driver.im/
You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.
 
 
Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Article Types

Countries / Regions

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Search Results (725)

Search Parameters:
Keywords = glucose toxicity

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
15 pages, 8140 KiB  
Article
Exposure to Acute Concentration of Malathion Induced Behavioral, Hematological, and Biochemical Toxicities in the Brain of Labeo rohita
by Sana Ullah, Saeed Ahmad, Muhammad Kashif Ashraf, Muhammad Bilal, Tariq Iqbal and Mahmoud M. Azzam
Life 2025, 15(2), 158; https://doi.org/10.3390/life15020158 - 23 Jan 2025
Viewed by 66
Abstract
A surge has been observed in the use of pesticides to boost agricultural yield in order to feed the continuously increasing human population. Different types and classes of broad-spectrum insecticides are in use, and the number is constantly increasing with the introduction of [...] Read more.
A surge has been observed in the use of pesticides to boost agricultural yield in order to feed the continuously increasing human population. Different types and classes of broad-spectrum insecticides are in use, and the number is constantly increasing with the introduction of new ones. Keeping in view the broad-spectrum effects of organophosphate pesticides including Malathion (MLN), their use is continuously increasing without appraising their toxic impacts on non-target organisms. The continuous rise in the use of MLN has led to its presence, persistence, and transport to water bodies globally, subsequently affecting commercially valuable aquatic organisms. The current study was conducted to assess MLN-induced hematological and biochemical toxicities in the brain of a commercially valuable indigenous major carp, rohu, Labeo rohita. The fish was exposed to an acute concentration of commercial-grade MLN. The LC50 of MLN (5 µg/L) led to behavioral inconsistencies and subtle impacts on the hematology (an increase in white blood cells and a reduction in red blood cells, hemoglobin, packed cell volume level, and mean corpuscular hemoglobin concentration) and biochemistry (an increase in reactive oxygen species, lipid peroxidation, activities of antioxidant enzymes (catalase, peroxidase, superoxide dismutase, glutathione, glutathione reductase, glutathione peroxidase, and glutathione-S-transferase) but a reduction in total protein content and activity of Na+/K+ ATPases) in the brain tissues. MLN also inhibited the activity of Acetylcholinesterase, while it led to an increase in Acetylcholine. Significant changes were observed in the serum biochemical profile; for example, glucose, cholesterol, potassium, urea, and total bilirubin increased, whereas total protein, sodium, chloride, albumin, and inorganic phosphate decreased after exposure. The current study clearly classified MLN as highly toxic to rohu. Therefore, the extra-judicious use of MLN should be strictly supervised. Studies concerning the real-world concentration of pesticides should be carried out on regular basis to mitigate the echoing issue of pesticide-based pollution. Full article
(This article belongs to the Section Animal Science)
Show Figures

Figure 1

Figure 1
<p>(<b>A</b>) ROS, (<b>B</b>) LPO, (<b>C</b>) total protein content, and (<b>D</b>) correlation among ROS, LPO, and total protein content in the brain of rohu at different time intervals. The different superscripted letters in (<b>A</b>), (<b>B</b>), and (<b>C</b>) indicate a significant difference at <span class="html-italic">p</span> &lt; 0.05 (ANOVA followed by LSD test). (<b>D</b>) shows Pearson correlation (considering r values &gt; 0.5 as significant at <span class="html-italic">p</span> &lt; 0.05) between ROS, LPO, and total protein content. A strong negative correlation (−0.986) was observed between ROS and total protein, and LPO and total protein, whereas a strong positive correlation (0.999) was observed between ROS and LPO.</p>
Full article ">Figure 2
<p>Acetylcholinesterase activity (µmol/min/mg/protein) and ACh (µM/g wet wt.) in the brain of rohu at different time intervals. The data are presented as the mean ± SE and were analyzed using ANOVA followed by LSD. The readings with different superscripted letters are significantly different at <span class="html-italic">p</span> &lt; 0.05.</p>
Full article ">Figure 3
<p>Activities of antioxidant enzymes ((<b>A</b>) catalase, (<b>B</b>) superoxide dismutase, (<b>C</b>) peroxidase, (<b>D</b>) glutathione, (<b>E</b>) glutathione reductase, (<b>F</b>) glutathione-S-transferase, (<b>G</b>) glutathione peroxidase, and (<b>H</b>) correlation among the studied antioxidant enzymes, ROS, and LPO) in the brain of rohu at different time intervals. (<b>A</b>–<b>G</b>) The data are presented as the mean ± SE and were analyzed using ANOVA followed by LSD. The readings with different superscripted letters are significantly different at <span class="html-italic">p</span> &lt; 0.05.</p>
Full article ">Figure 4
<p>Activity of sodium/potassium ATPases in the brain of rohu at different time intervals. The data are presented as the mean ± SE and were analyzed using ANOVA followed by LSD. The readings with different superscripted letters are significantly different at <span class="html-italic">p</span> &lt; 0.05.</p>
Full article ">Figure 5
<p>Hematological ((<b>A</b>) WBCs, (<b>B</b>) RBCs, (<b>C</b>) hemoglobin, (<b>D</b>) PCV, (<b>E</b>) MCV, (<b>F</b>) MCH, (<b>G</b>) MCHC, and (<b>H</b>) hematocrit) toxicity induced in rohu after exposure to an acute concentration of Malathion. The data are presented as the mean ± SE and were analyzed using ANOVA followed by LSD. The readings with different superscripted letters are significantly different at <span class="html-italic">p</span> &lt; 0.05.</p>
Full article ">Figure 6
<p>Blood biochemical profile ((<b>A</b>) glucose, (<b>B</b>) total protein, (<b>C</b>) cholesterol, (<b>D</b>) sodium, (<b>E</b>) potassium, (<b>F</b>) chloride, (<b>G</b>) urea, (<b>H</b>) albumin, (<b>I</b>) total bilirubin, (<b>J</b>) inorganic phosphate, (<b>K</b>) ALT, and (<b>L</b>) AST) after exposure to an acute concentration of Malathion. The data are presented as the mean ± SE and were analyzed using ANOVA followed by LSD. The readings with different superscripted letters are significantly different at <span class="html-italic">p</span> &lt; 0.05.</p>
Full article ">
22 pages, 3711 KiB  
Article
Evaluation of Bioactive Compounds and Chemical Elements in Herbs: Effectiveness of Choline Chloride-Based Deep Eutectic Solvents in Ultrasound-Assisted Extraction
by Aleksandra Szydłowska-Czerniak, Agnieszka Kowaluk, Michał Strzelec, Tomasz Sawicki and Małgorzata Tańska
Molecules 2025, 30(2), 368; https://doi.org/10.3390/molecules30020368 - 17 Jan 2025
Viewed by 470
Abstract
In this study, the effectiveness of three choline chloride (ChCl)-based deep eutectic solvents (DESs) formed using malonic acid (MalA), glycerol (Gly), and glucose (Glu) as hydrogen bond donors and two conventional solvents (50% methanol and 50% ethanol) for ultrasonic-assisted extraction (UAE) of antioxidant [...] Read more.
In this study, the effectiveness of three choline chloride (ChCl)-based deep eutectic solvents (DESs) formed using malonic acid (MalA), glycerol (Gly), and glucose (Glu) as hydrogen bond donors and two conventional solvents (50% methanol and 50% ethanol) for ultrasonic-assisted extraction (UAE) of antioxidant compounds from four herbs (chamomile, lemon balm, nettle, and spearmint) were estimated. The antioxidant capacity (AC) of the obtained herb extracts was determined by the modified 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS), 2,2-diphenyl-1-picrylhydrazyl (DPPH), and cupric reducing antioxidant capacity (CUPRAC) methods. Profiles of phenolic acids, flavonoid aglycones, and flavonoid glycosides in the green and conventional herb extracts were quantitatively analyzed using ultra-performance liquid chromatography (UPLC). Among the prepared DESs, the highest antioxidant potential and total contents of phenolic acids, flavonoid aglycones, and flavonoid glycosides in herb extracts were achieved using ChCl:MalA (1:1). Unexpectedly, the selected green solvents extracted significantly lower amounts of total antioxidants from the investigated herbs than 50% alcohols. Additionally, macroelements (K, Na, Ca, Mg), micronutrients (Mn, Zn, Fe, Cu), and a toxic element (Cd) in four herbs were analyzed using inductively coupled plasma–mass spectrometry (ICP–MS). Determining the compositions of antioxidants and elements in herbs is essential for understanding their nutritive importance when applied in the food, cosmetic, and pharmaceutical industries. Full article
(This article belongs to the Section Natural Products Chemistry)
Show Figures

Figure 1

Figure 1
<p>Scanning electron micrographs of spearmint powder before (<b>a</b>–<b>c</b>) and after ultrasound-assisted extraction with 50% methanol (<b>d</b>–<b>f</b>), 50% ethanol (<b>g</b>–<b>i</b>), choline chloride:malonic acid (1:1) (<b>j</b>–<b>l</b>) at 500× (<b>a</b>,<b>d</b>,<b>g</b>,<b>j</b>), 1000× (<b>b</b>,<b>e</b>,<b>h</b>,<b>k</b>), and 5000× (<b>c</b>,<b>f</b>,<b>i</b>,<b>l</b>) magnification, respectively.</p>
Full article ">Figure 2
<p>EDS spectra (<b>a</b>,<b>d</b>,<b>g</b>,<b>j</b>), SEM images (<b>b</b>,<b>e</b>,<b>h</b>,<b>k</b>), and mapping images via SEM–EDS (<b>c</b>,<b>f</b>,<b>i</b>,<b>l</b>) of spearmint powder before and after ultrasound-assisted extraction with 50% methanol, 50% ethanol, and choline chloride:malonic acid (1:1).</p>
Full article ">Figure 2 Cont.
<p>EDS spectra (<b>a</b>,<b>d</b>,<b>g</b>,<b>j</b>), SEM images (<b>b</b>,<b>e</b>,<b>h</b>,<b>k</b>), and mapping images via SEM–EDS (<b>c</b>,<b>f</b>,<b>i</b>,<b>l</b>) of spearmint powder before and after ultrasound-assisted extraction with 50% methanol, 50% ethanol, and choline chloride:malonic acid (1:1).</p>
Full article ">
7 pages, 185 KiB  
Commentary
Integrating New Approach Methodologies to Address Environmental Pancreatic Toxicity and Metabolic Disorders
by Yue Ge
Biology 2025, 14(1), 85; https://doi.org/10.3390/biology14010085 - 17 Jan 2025
Viewed by 307
Abstract
Advancing our understanding of pancreatic toxicity and metabolic disorders caused by environmental exposures requires innovative approaches. The pancreas, a vital organ for glucose regulation, is increasingly recognized as a target of harm from environmental chemicals and dietary factors. Traditional toxicological methods, while foundational, [...] Read more.
Advancing our understanding of pancreatic toxicity and metabolic disorders caused by environmental exposures requires innovative approaches. The pancreas, a vital organ for glucose regulation, is increasingly recognized as a target of harm from environmental chemicals and dietary factors. Traditional toxicological methods, while foundational, often fail to address the mechanistic complexities of pancreatic dysfunction, particularly under real-world conditions involving multiple exposures. New Approach Methodologies (NAMs)—including high-throughput screening (HTS), OMICS technologies, computational modeling, and advanced in vitro systems—offer transformative tools to tackle these challenges. NAMs enable the identification of mechanistic pathways, improve testing efficiency, and reduce reliance on animal testing. This commentary explores the integration of NAMs into pancreatic toxicity screening, addresses critical gaps in evaluating the cumulative risks of chemical and dietary exposures, and proposes solutions for integrating the pancreas into toxicity screening through NAMs. By highlighting recent advancements and emphasizing their adoption in environmental toxicity assessment frameworks, this work demonstrates the potential of NAMs to revolutionize environmental health research, inspire interdisciplinary collaboration, and protect public health. Full article
17 pages, 3850 KiB  
Article
Glucose as a Metabolic Enhancer: Promoting Nonylphenol Detoxification by Chlorella pyrenoidosa
by Jinrui Yuan, Lin Zhao, Yanting Li, Guodong Xing, Danning Chen and Yongkui Yang
Water 2025, 17(2), 244; https://doi.org/10.3390/w17020244 - 16 Jan 2025
Viewed by 301
Abstract
The environmental treatment of endocrine-disrupting compounds (EDCs) has attracted significant attention. Nonylphenol (NP), a highly toxic EDC with widespread distribution, presents an urgent challenge requiring effective removal strategies. Although microalgae-based treatments offer environmentally friendly and cost-effective solutions, the high toxicity level of NP [...] Read more.
The environmental treatment of endocrine-disrupting compounds (EDCs) has attracted significant attention. Nonylphenol (NP), a highly toxic EDC with widespread distribution, presents an urgent challenge requiring effective removal strategies. Although microalgae-based treatments offer environmentally friendly and cost-effective solutions, the high toxicity level of NP impedes this process. Analysis was conducted on cell biomass, cell morphology, extracellular polymeric substances (EPSs), and the degradation of nonylphenol in Chlorella pyrenoidosa treated with nonylphenol and glucose. Glucose restored the algal biomass to 2.23 times its original level, reduced cellular damage, and maintained normal physiological activities. Glucose also stimulated algal metabolism and promoted the secretion of EPSs. The polysaccharide content of soluble EPSs (S-EPSs) increased by 32.7%, whereas that of the bound EPSs (B-EPSs) increased by 55.5%. The three-dimensional excitation–emission matrix fluorescence spectroscopy of B-EPS indicated that glucose enhanced tryptophan secretion. Glucose showed great potential as a biostimulant to enhance NP bioremediation efficiency in aquatic ecosystems. This finding indicates that the nonylphenol remediation of wastewater can be integrated with microalgal biomass recovery, creating opportunities for revenue generation. Full article
Show Figures

Figure 1

Figure 1
<p>(<b>a</b>,<b>c</b>) Algal biomass of various treatments throughout 5-day culture period. (<b>b</b>,<b>d</b>) Specific growth rate of different treatments throughout 5-day culture period.</p>
Full article ">Figure 2
<p>Scanning electron microscopy images of <span class="html-italic">C. pyrenoidosa</span> under different conditions: (<b>a</b>) original <span class="html-italic">C. pyrenoidosa</span> without addition of NP and glucose; (<b>b</b>) <span class="html-italic">C. pyrenoidosa</span> with 4.0 mg/L NP; (<b>c</b>) <span class="html-italic">C. pyrenoidosa</span> with 4.0 mg/L NP and 0.4 g/L glucose at end of cultivation period.</p>
Full article ">Figure 3
<p>(<b>a</b>) NP removal rate at different concentrations using <span class="html-italic">C. pyrenoidosa</span> during 5-day culture period. (<b>b</b>) Contributions of adsorption, absorption, and degradation by algae to NP removal. C represents 0.4 g/L glucose. Different letters (a, b) indicate statistically significant disparities between groups. <span class="html-italic">p</span> &lt; 0.05.</p>
Full article ">Figure 4
<p>Degradation pathway of NP in <span class="html-italic">Chlorella pyrenoidosa.</span> The compounds (1)–(6) were degradation byproducts detected by UPLC—QTOF—MS.</p>
Full article ">Figure 5
<p>(<b>a</b>) Protein content of EPS in <span class="html-italic">C. pyrenoidosa</span>. (<b>b</b>) Polysaccharide contents of EPS in <span class="html-italic">C. pyrenoidosa</span>. C represents 0.4 g/L glucose. (<b>c</b>) Tricarboxylic acid cycle in microalgae. Different letters (a, b, c, d) indicate statistically significant disparities between groups. <span class="html-italic">p</span> &lt; 0.05.</p>
Full article ">Figure 6
<p>(<b>a</b>–<b>c</b>) Three-dimensional excitation and emission matrix fluorescence spectra of B-EPS in <span class="html-italic">C. pyrenoidosa</span> on day 2: (<b>a</b>) 0.0 mg/L NP; (<b>b</b>) 4.0 mg/L NP; (<b>c</b>) 4.0 mg/L NP with C. (<b>d</b>–<b>f</b>) Three-dimensional excitation and emission matrix fluorescence spectra of B-EPS of <span class="html-italic">C. pyrenoidosa</span> at cultured end-stage: (<b>d</b>) 0.0 mg/L NP; (<b>e</b>) 4.0 mg/L NP; (<b>f</b>) 4.0 mg/L NP with C. C represents 0.4 g/L glucose. (I) indicates tyrosine-like (Ex/Em: 260–280 nm/295–312 nm) compounds and (II) indicates tryptophan-like (Ex/Em: 270–280 nm/330–350 nm) compounds.</p>
Full article ">
38 pages, 1123 KiB  
Review
Proteostasis Decline and Redox Imbalance in Age-Related Diseases: The Therapeutic Potential of NRF2
by Brigitta Buttari, Antonella Tramutola, Ana I. Rojo, Niki Chondrogianni, Sarmistha Saha, Alessandra Berry, Letizia Giona, Joana P. Miranda, Elisabetta Profumo, Sergio Davinelli, Andreas Daiber, Antonio Cuadrado and Fabio Di Domenico
Biomolecules 2025, 15(1), 113; https://doi.org/10.3390/biom15010113 - 13 Jan 2025
Viewed by 670
Abstract
Nuclear factor erythroid 2-related factor 2 (NRF2) is a master regulator of cellular homeostasis, overseeing the expression of a wide array of genes involved in cytoprotective processes such as antioxidant and proteostasis control, mitochondrial function, inflammation, and the metabolism of lipids and glucose. [...] Read more.
Nuclear factor erythroid 2-related factor 2 (NRF2) is a master regulator of cellular homeostasis, overseeing the expression of a wide array of genes involved in cytoprotective processes such as antioxidant and proteostasis control, mitochondrial function, inflammation, and the metabolism of lipids and glucose. The accumulation of misfolded proteins triggers the release, stabilization, and nuclear translocation of NRF2, which in turn enhances the expression of critical components of both the proteasomal and lysosomal degradation pathways. This process facilitates the clearance of toxic protein aggregates, thereby actively maintaining cellular proteostasis. As we age, the efficiency of the NRF2 pathway declines due to several factors including increased activity of its repressors, impaired NRF2-mediated antioxidant and cytoprotective gene expression, and potential epigenetic changes, though the precise mechanisms remain unclear. This leads to diminished antioxidant defenses, increased oxidative damage, and exacerbated metabolic dysregulation and inflammation—key contributors to age-related diseases. Given NRF2’s role in mitigating proteotoxic stress, the pharmacological modulation of NRF2 has emerged as a promising therapeutic strategy, even in aged preclinical models. By inducing NRF2, it is possible to mitigate the damaging effects of oxidative stress, metabolic dysfunction, and inflammation, thus reducing protein misfolding. The review highlights NRF2’s therapeutic implications for neurodegenerative diseases and cardiovascular conditions, emphasizing its role in improving proteostasis and redox homeostasis Additionally, it summarizes current research into NRF2 as a therapeutic target, offering hope for innovative treatments to counteract the effects of aging and associated diseases. Full article
Show Figures

Figure 1

Figure 1
<p>Schematic overview of the NRF2 interaction mechanisms with the unfold protein response (UPR), the mTOR/autophagy pathways and the ubiquitin-proteasome system (UPS). See details in the text (created with BioRender, Toronto, ON, Canada).</p>
Full article ">Figure 2
<p>Schematic overview of the central role of NRF2 in regulating protein homeostasis and redox balance. Green lines describe the interventions of NRF2 in homeostatic mechanisms (created with BioRender, Toronto, ON, Canada).</p>
Full article ">
21 pages, 3747 KiB  
Article
Polyphenolic Hispolon Derived from Medicinal Mushrooms of the Inonotus and Phellinus Genera Promotes Wound Healing in Hyperglycemia-Induced Impairments
by Yi-Shan Liu, Mei-Chou Lai, Yu-Cheng Tzeng and I-Min Liu
Nutrients 2025, 17(2), 266; https://doi.org/10.3390/nu17020266 - 13 Jan 2025
Viewed by 587
Abstract
Background: This study investigated the wound-healing potential of hispolon, a polyphenolic pigment derived from medicinal mushrooms, under diabetic conditions using both in vitro and in vivo models. Methods: In the in vitro assays, L929 fibroblast cells exposed to high glucose (33 [...] Read more.
Background: This study investigated the wound-healing potential of hispolon, a polyphenolic pigment derived from medicinal mushrooms, under diabetic conditions using both in vitro and in vivo models. Methods: In the in vitro assays, L929 fibroblast cells exposed to high glucose (33 mmol/L) were treated with hispolon at concentrations of 2.5, 5, 7.5, or 10 μmol/L. In the in vivo assays, streptozotocin-induced diabetic rats with excision wounds received daily topical applications of 0.2 g of 5% (w/w) hispolon ointment. Results: Hispolon improved cell viability; suppressed oxidative stress by reducing reactive oxygen species, lipid peroxidation, and oxidative DNA damage; and restored the reduced glutathione/oxidized glutathione ratio. The scratch assay demonstrated that hispolon at 10 μmol/L enhanced fibroblast migration impaired by high-glucose conditions. Treatment with 5% (w/w) hispolon ointment accelerated wound contraction, reduced the epithelialization time, and enhanced tissue regeneration with an efficacy comparable to that of Fespixon® cream, as shown by histological findings of increased fibroblast activity, collagen deposition, and capillary growth. Hispolon ointment also modulated macrophage polarization in diabetic wounds by reducing M1 markers and enhancing M2 markers. In a diabetic rat dead-space-wound model, 5% (w/w) hispolon ointment reduced the levels of pro-inflammatory cytokines, increased those of anti-inflammatory cytokines and growth factors, and stimulated Type I and III collagen synthesis, effectively promoting wound healing. In incisional wounds, hispolon ointment improved the wound-breaking strength, showing results comparable to that of Fespixon® cream. Safety assessments confirmed that hispolon ointment showed no acute dermal toxicity. These findings underscore hispolon’s potential as a promising candidate for diabetic wound management by mitigating oxidative stress, enhancing tissue regeneration, and accelerating wound healing. Full article
(This article belongs to the Special Issue Medicinal Plants and Natural Products for Human Health)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Chemical structure of hispolon.</p>
Full article ">Figure 2
<p>Effect of hispolon on cell viability in L929 cells. (<b>A</b>) Cell viability in L929 cells cultured with glucose concentrations ranging from 5.5, 11, and 22 mmol/L to 33 mmol/L for 24 h or 48 h. (<b>B</b>) Cells were pretreated with different concentrations of hispolon (2.5, 5, 7.5, or 10 μmol/L) for 1 h and then exposed to normal glucose (5.5 mmol/L; NG) or high glucose (33 mmol/L; HG) for an additional 48 h. Cell viability was determined by the XTT assay. The results are presented as the mean ± SD of five independent experiments (<span class="html-italic">n</span> = 5), each of which was performed in triplicate. Statistical significance is indicated as follows: <sup>a</sup> <span class="html-italic">p</span> &lt; 0.05 and <sup>b</sup> <span class="html-italic">p</span> &lt; 0.01, compared with the data from vehicle-treated NG-incubated cells (control group); <sup>c</sup> <span class="html-italic">p</span> &lt; 0.05 and <sup>d</sup> <span class="html-italic">p</span> &lt; 0.01, compared with the data from vehicle-treated HG-incubated cells.</p>
Full article ">Figure 3
<p>Influence of hispolon on oxidative stress and antioxidative defense responses in L929 cells under high-glucose conditions. L929 cells were pretreated with hispolon at varying concentrations (2.5, 5, 7.5, or 10 μmol/L) for 1 h before being subjected to either normal-glucose (5.5 mmol/L; NG) or high-glucose (33 mmol/L; HG) conditions for an additional 48 h. (<b>A</b>) Intracellular ROS levels were assessed using the oxidation-sensitive fluorescent probe DCFH-DA. (<b>B</b>) Lipid peroxidation was evaluated via the TBARS assay. (<b>C</b>) Levels of 8-OHdG were quantified utilizing a commercially-supplied ELISA kit. (<b>D</b>) The ratio of GSH to GSSG in cells was assessed using a commercially provided kit. All experiments were conducted in triplicate, and results are expressed as the mean ± SD from five independent experiments (<span class="html-italic">n</span> = 5). Statistical significance is indicated as follows: <sup>a</sup> <span class="html-italic">p</span> &lt; 0.05 and <sup>b</sup> <span class="html-italic">p</span> &lt; 0.01, compared with the data from vehicle-treated NG-incubated cells (control group); <sup>c</sup> <span class="html-italic">p</span> &lt; 0.05 and <sup>d</sup> <span class="html-italic">p</span> &lt; 0.01, compared with the data from vehicle-treated HG-incubated cells.</p>
Full article ">Figure 4
<p>Effect of hispolon on cell migration in high-glucose environments. L929 cells were pretreated with different hispolon concentrations (2.5, 5, 7.5, or 10 μmol/L) for 1 h, followed by exposure to either normal glucose (5.5 mmol/L, NG) or high glucose (33 mmol/L, HG) for 48 h. (<b>A</b>) A scratch migration assay was performed, and optical images showing cells migrating into the wound gap were taken at 0 and 24 h at a 100× magnification. (<b>B</b>) The migration distance of the cells was measured using ImageJ software version 1.38. All experiments were conducted in triplicate, and the results are expressed as the mean ± SD from five independent experiments (<span class="html-italic">n</span> = 5). Statistical significance is indicated as follows: <sup>a</sup> <span class="html-italic">p</span> &lt; 0.05 and <sup>b</sup> <span class="html-italic">p</span> &lt; 0.01, compared with the data from vehicle-treated NG-incubated cells (control group); <sup>c</sup> <span class="html-italic">p</span> &lt; 0.05 and <sup>d</sup> <span class="html-italic">p</span> &lt; 0.01, compared with the data from vehicle-treated HG-incubated cells.</p>
Full article ">Figure 5
<p>Effects of hispolon on plasma glucose levels and wound contraction in excision wounds in rats. (<b>A</b>) Plasma glucose concentration, (<b>B</b>) percentage of wound contraction, and (<b>C</b>) epithelialization period was measured in STZ-diabetic rats treated with experimental ointments using an excision-wound model. Values (mean ± SD) were obtained from each group of 8 animals. <sup>a</sup> <span class="html-italic">p</span> &lt; 0.05 and <sup>b</sup> <span class="html-italic">p</span> &lt; 0.01, compared with the values of normal rats without treatment on the indicated post-wounding day. <sup>c</sup> <span class="html-italic">p</span> &lt; 0.05 and <sup>d</sup> <span class="html-italic">p</span> &lt; 0.01, compared with the values of STZ-diabetic rats without treatment on the indicated post-wounding day.</p>
Full article ">Figure 6
<p>Effects of hispolon on macrophage phenotype regulation and tissue regeneration in rat excision wounds. (<b>A</b>) Immunohistochemistry was performed on day 7 post-wounding to identify M1 and M2 macrophage populations in the excision wounds. The upper panel displays immunohistochemical staining images, while the lower panel presents quantified data of the positive staining (dark brown) for CD86 and CD206, indicating M1 and M2 macrophages, respectively. Photomicrographs were captured at ×100 magnification. The positive staining observed in the treated group was compared to the staining values recorded in the untreated control group of normal rats, (<b>B</b>) Histological analysis of the wound healing was performed on day 14 post-surgery using hematoxylin and eosin staining. The upper panel presents photomicrographs at ×100 magnification. The lower panel provides the corresponding histopathological scores for the experimental groups. Values (mean ± SD) were obtained from each group of 8 animals. <sup>a</sup> <span class="html-italic">p</span> &lt; 0.05 and <sup>b</sup> <span class="html-italic">p</span> &lt; 0.01, compared with the values of normal rats without treatment (control). <sup>c</sup> <span class="html-italic">p</span> &lt; 0.05 and <sup>d</sup> <span class="html-italic">p</span> &lt; 0.01, compared with the values of STZ-diabetic rats without treatment.</p>
Full article ">Figure 7
<p>Effects of hispolon on pro-inflammatory and anti-inflammatory cytokine levels, growth factor concentrations, and collagen properties in granulation tissue of dead-space wounds in rats after 7 days. (<b>A</b>) The levels of pro-inflammatory cytokines (TNF-α, IL-6, IL-1β) and the anti-inflammatory cytokine IL-10 were quantified. (<b>B</b>) The concentrations of growth factors, including FGF21, TGF-β1, EGF, and VEGF, were measured. (<b>C</b>) The properties of collagen, focusing on Type I and Type III collagen, were analyzed. Values (mean ± SD) were obtained from each group of 8 animals. <sup>a</sup> <span class="html-italic">p</span> &lt; 0.05 and <sup>b</sup> <span class="html-italic">p</span> &lt; 0.01, compared with the values of normal rats without treatment. <sup>c</sup> <span class="html-italic">p</span> &lt; 0.05 and <sup>d</sup> <span class="html-italic">p</span> &lt; 0.01, compared with the values of STZ-diabetic rats without treatment.</p>
Full article ">Figure 8
<p>Effects of hispolon on the wound-breaking strength (WBS) in an incision-wound model. Values (mean ± SD) were obtained from each group of 8 animals. <sup>a</sup> <span class="html-italic">p</span> &lt; 0.05 and <sup>b</sup> <span class="html-italic">p</span> &lt; 0.01, compared with the values of normal rats without treatment. <sup>c</sup> <span class="html-italic">p</span> &lt; 0.05 and <sup>d</sup> <span class="html-italic">p</span> &lt; 0.01, compared to the values of STZ-diabetic rats without treatment.</p>
Full article ">
20 pages, 3440 KiB  
Article
Gboxin Induced Apoptosis and Ferroptosis of Cervical Cancer Cells by Promoting Autophagy-Mediated Inhibition of Nrf2 Signaling Under Low-Glucose Conditions
by Wei Liu, Junlin Lu, Jiarui Li, Lu Wang, Yao Chen, Yulun Wu, Ziying Zhang, Jingying Zhang, Feng Gao, Chaoran Jia, Yongli Bao, Xiaoguang Yang and Zhenbo Song
Int. J. Mol. Sci. 2025, 26(2), 502; https://doi.org/10.3390/ijms26020502 - 9 Jan 2025
Viewed by 347
Abstract
Cervical cancer poses a substantial threat to women’s health, underscoring the necessity for effective therapeutic agents with low toxicity that specifically target cancer cells. As cancer progresses, increased glucose consumption causes glucose scarcity in the tumor microenvironment (TME). Consequently, it is imperative to [...] Read more.
Cervical cancer poses a substantial threat to women’s health, underscoring the necessity for effective therapeutic agents with low toxicity that specifically target cancer cells. As cancer progresses, increased glucose consumption causes glucose scarcity in the tumor microenvironment (TME). Consequently, it is imperative to identify pharmacological agents capable of effectively killing cancer cells under conditions of low glucose availability within the TME. Previous studies showed that Gboxin, a small molecule, inhibited glioblastoma (GBM) growth by targeting ATP synthase without harming normal cells. However, its effects and mechanisms in cervical cancer cells in low-glucose environments are not clear. This study indicates that Gboxin notably enhanced autophagy, apoptosis, and ferroptosis in cervical cells under low-glucose conditions without significantly affecting cell survival under normal conditions. Further analysis revealed that Gboxin inhibited the activity of complex V and the production of ATP, concurrently leading to a reduction in mitochondrial membrane potential and the mtDNA copy number under low-glucose culture conditions. Moreover, Gboxin inhibited tumor growth under nutrient deprivation conditions in vivo. A mechanistic analysis revealed that Gboxin activated the AMPK signaling pathway by targeting mitochondrial complex V. Furthermore, increased AMPK activation subsequently promoted autophagy and reduced p62 protein levels. The decreased levels of p62 protein facilitated the degradation of Nrf2 by regulating the p62-Keap1-Nrf2 axis, thereby diminishing the antioxidant capacity of cervical cancer cells, ultimately leading to the induction of apoptosis and ferroptosis. This study provides a better theoretical basis for exploring Gboxin as a potential drug for cervical cancer treatment. Full article
(This article belongs to the Section Molecular Oncology)
Show Figures

Figure 1

Figure 1
<p>Gboxin inhibited the viability of cervical cancer cells under low-glucose conditions. (<b>A</b>) The effect of Gboxin on the viability of HeLa and SiHa cells under normal culture conditions was measured using an MTT assay. (<b>B</b>) The inhibitory effect of Gboxin on the viability of HeLa and SiHa cells under low-glucose conditions was measured using an MTT assay. (<b>C</b>) Trypan blue staining was used to detect non-viable cells after Gboxin treatment under low-glucose conditions. Scale bar = 100 μm. (<b>D</b>) Cell death was quantified after trypan blue staining and expressed as a mean% of the control. * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, and *** <span class="html-italic">p</span> &lt; 0.001. ns, no significance.</p>
Full article ">Figure 2
<p>Gboxin triggered autophagy and apoptosis in cervical cancer cells. (<b>A</b>) The rescue effect of Nec-1 on Gboxin-induced cell death in HeLa cells (left) and SiHa cells (right) under low-glucose conditions. (<b>B</b>) The rescue effect of apoptosis inhibitor Z-VAD on Gboxin-induced cell death under low-glucose conditions. (<b>C</b>,<b>D</b>) The expression of apoptosis-related proteins was measured by Western blotting after Gboxin treatment under low-glucose conditions (<b>C</b>), and the results were quantified with Image J software version 1.54f (<b>D</b>). β-actin was used as a loading control. (<b>E</b>) The rescue effect of autophagy inhibitor 3-MA on Gboxin-induced cell death under low-glucose conditions. (<b>F</b>,<b>G</b>) The expression of autophagy-related proteins under low-glucose conditions was measured by Western blotting after Gboxin treatment (<b>F</b>), and the results were quantified with Image J software version 1.54f (<b>G</b>). β-actin was used as a loading control. * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, and *** <span class="html-italic">p</span> &lt; 0.001. ns, no significance.</p>
Full article ">Figure 3
<p>Gboxin induced ferroptosis of cervical cancer cells. (<b>A</b>) The rescue effect of ferroptosis inhibitor Fer-1 on Gboxin-induced cell death under low-glucose conditions. (<b>B</b>–<b>E</b>) The effects of Gboxin treatment on the levels of Fe<sup>2+</sup> (<b>B</b>), LPO (<b>C</b>), MDA (<b>D</b>), and ROS (<b>E</b>) and the NADP<sup>+</sup>/NADPH ratio (<b>F</b>) under low-glucose conditions. (<b>G</b>) The effect of Gboxin treatment on the mRNA levels of ferroptosis-related genes under low-glucose conditions was measured by qRT-PCR. (<b>H</b>,<b>I</b>) The expression of ferroptosis-related proteins was examined after Gboxin treatment under low-glucose conditions (<b>H</b>), and the results were quantified with Image J software version 1.54f (<b>I</b>). β-actin was used as a loading control. * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, and *** <span class="html-italic">p</span> &lt; 0.001. ns, no significance.</p>
Full article ">Figure 4
<p>Gboxin did not influence glycolysis and the expression of rate-limiting enzymes within the TCA cycle. (<b>A</b>,<b>B</b>) The effects of Gboxin treatments on glucose consumption (<b>A</b>) and lactate secretion (<b>B</b>) of HeLa and SiHa cells under low-glucose conditions. (<b>C</b>–<b>F</b>) The expression of proteins in glycolysis (<b>C</b>) and TCA cycle (<b>D</b>) under low-glucose conditions was measured by Western blotting, and the results were quantified with Image J software version 1.54f (<b>E</b>,<b>F</b>). β-actin was used as a loading control. * <span class="html-italic">p</span> &lt; 0.05; ** <span class="html-italic">p</span> &lt; 0.01. ns, no significance.</p>
Full article ">Figure 5
<p>Gboxin treatment resulted in mitochondrial dysfunction under low-glucose conditions. (<b>A</b>) The effect of Gboxin on mitochondrial complex V activity in HeLa and SiHa cells under low-glucose conditions. (<b>B</b>) The effect of Gboxin on ATP levels in HeLa and SiHa cells under low-glucose conditions. (<b>C</b>) The effect of Gboxin on the mitochondrial membrane potential in HeLa (top) and SiHa (bottom) cells under low-glucose conditions was measured by the fluorescent probe TMRE. Top scale bar = 200 μm; bottom scale bar = 100 μm. (<b>D</b>) The effect of Gboxin on MPTP opening in HeLa (top) and SiHa (bottom) cells under low-glucose conditions was measured by Calcein AM staining. Top scale bar = 200 μm; bottom scale bar = 100 μm. (<b>E</b>) The effect of Gboxin on the mtDNA copy number in HeLa and SiHa cells under low-glucose conditions. (<b>F</b>) The effect of Gboxin on the mtDNA copy number in HeLa and SiHa cells under low-glucose conditions was measured by Mito tracker staining. Scale bar = 20 μm; * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, and *** <span class="html-italic">p</span> &lt; 0.001.</p>
Full article ">Figure 6
<p>Gboxin inhibited tumor growth under nutrient deprivation conditions. (<b>A</b>) HeLa cells were injected subcutaneously into nude mice to evaluate tumor growth under normal feeding and intermittent fasting conditions. (<b>B</b>) Photographs of tumor-bearing mice (<span class="html-italic">n</span> = 6 per group). (<b>C</b>,<b>D</b>) The tumor volume (<b>C</b>) and weight (<b>D</b>) of each group were measured after the intra-peritoneal injection of Gboxin under normal feeding and intermittent fasting conditions. (<b>E</b>) The tumor growth curves in four groups with different treatments. (<b>F</b>) The expression of apoptosis-, autophagy-, and ferroptosis-related proteins in tumor tissues were measured by Western blotting (<span class="html-italic">n</span> = 6 per group). * <span class="html-italic">p</span> &lt; 0.05 and ** <span class="html-italic">p</span> &lt; 0.01; ns, no significance.</p>
Full article ">Figure 7
<p>Gboxin activated the AMPK signaling pathway. (<b>A</b>) The reversal effect of exogenous ATP addition on Gboxin-induced cell death under low-glucose conditions. (<b>B</b>) Activation of AMPK signaling was observed after Gboxin treatment under low-glucose conditions, and the results were quantified with Image J software version 1.54f. β-actin was used as a loading control. (<b>C</b>,<b>D</b>) Activation of AMPK signaling was observed after the treatment with Dor under low-glucose conditions (<b>C</b>), and the results were quantified with Image J software version 1.54f (<b>D</b>). β-actin was used as a loading control. * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, and *** <span class="html-italic">p</span> &lt; 0.001.</p>
Full article ">Figure 8
<p>The overexpression of the p62 protein reversed the inhibitory effect of Gboxin. (<b>A</b>,<b>B</b>) The expression of p62 was observed in HeLa and SiHa cells after treatment with Dor (<b>A</b>), and the results were quantified with Image J software version 1.54f (<b>B</b>). β-actin was used as a loading control. (<b>C</b>,<b>D</b>) p62 overexpression was observed in HeLa and SiHa cells (<b>C</b>), and it had a reversal effect on Gboxin-induced cell death (<b>D</b>). β-actin was used as a loading control. (<b>E</b>,<b>F</b>) The reversal effect of p62 overexpression on the expression of Nrf2 and GPX4 was observed (<b>E</b>), and the results were quantified with Image J software version 1.54f (<b>F</b>). β-actin was used as a loading control. (<b>G</b>) A working model of Gboxin under low-glucose conditions. * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, and *** <span class="html-italic">p</span> &lt; 0.001.</p>
Full article ">
38 pages, 4838 KiB  
Review
Sesquiterpene Lactones as Promising Anti-Glioblastoma Drug Candidates Exerting Complex Effects on Glioblastoma Cell Viability and Proneural–Mesenchymal Transition
by Andrey V. Markov, Arseny D. Moralev and Kirill V. Odarenko
Biomedicines 2025, 13(1), 133; https://doi.org/10.3390/biomedicines13010133 - 8 Jan 2025
Viewed by 460
Abstract
Glioblastoma is one of the most aggressive brain cancers, characterized by active infiltrative growth and high resistance to radiotherapy and chemotherapy. Sesquiterpene triterpenoids (STLs) and their semi-synthetic analogs are considered as a promising source of novel anti-tumor agents due to their low systemic [...] Read more.
Glioblastoma is one of the most aggressive brain cancers, characterized by active infiltrative growth and high resistance to radiotherapy and chemotherapy. Sesquiterpene triterpenoids (STLs) and their semi-synthetic analogs are considered as a promising source of novel anti-tumor agents due to their low systemic toxicity and multi-target pharmacological effects on key processes associated with tumor progression. The current review aims to systematize the knowledge on the anti-glioblastoma potential of STLs accumulated over the last decade and to identify key processes in glioblastoma cells that are most susceptible to the action of STLs. An analysis of published data clearly demonstrated that STLs, which can successfully cross the blood–brain barrier, exert a complex inhibitory effect on glioblastoma cells through the induction of the “mitochondrial dysfunction–oxidative stress–apoptosis” axis, the inhibition of glucose metabolism and cell cycle phase transition, and the suppression of glioblastoma cell motility and invasion through the blockade of proneural–mesenchymal transition. Taken together, this review highlights the promising anti-glioblastoma potential of STLs, which are not only able to induce glioblastoma cell death, but also effectively affect their diffusive spread, and suggests the possible directions for further investigation of STLs in the context of glioblastoma to better understand their mechanism of action. Full article
(This article belongs to the Special Issue Feature Reviews in Cell Death)
Show Figures

Figure 1

Figure 1
<p>Structures of natural STLs and their derivatives with anti-glioblastoma activities.</p>
Full article ">Figure 2
<p>Anti-glioblastoma effects of natural STLs and their derivatives. (<b>A</b>) Effect of STLs on key processes associated with glioblastoma cell death. Downward (↓) and upward (↑) bold arrows indicate down-regulation and up-regulation of the processes, respectively. Dull arrows (┴) indicate inhibition. (<b>B</b>) In vivo anti-glioblastoma effects of STLs in subcutaneous xenograft models. Different colors represent different types of STLs.</p>
Full article ">Figure 3
<p>Proneural–mesenchymal transition (PMT) as a target for STLs. (<b>A</b>) Cellular plasticity in glioblastoma. In the tumor microenvironment, glioblastoma cells can switch between proneural and mesenchymal states, which differ in morphology and marker expression. The transition to the mesenchymal state, known as PMT, results in an invasive phenotype and is regulated by a subset of transcription factors (TFs), including both classical EMT TFs such as Slug, Snail, and Twis, and PMT-specific TFs such as TAZ, STAT3, and bHLH-H2. (<b>B</b>) Pathways that induce PMT. Several factors from the tumor microenvironment, including hypoxia, necrosis, inflammation, and soluble growth factors, can induce PMT. These factors activate a complex regulatory network of signaling pathways in which NF-κB and GSK-3β serve as key interconnected “hubs” (shown in yellow). This network ultimately activates PMT TFs, which are organized in a hierarchy with a “regulatory core” of PMT-specific TFs (highlighted in orange) and supporting TFs. In addition, several deubiquitinases form a “stabilizing module” (marked in red) that maintains PMT by extending the half-life of PMT TFs. (<b>C</b>) STL-PMT interaction network. Based on a manual literature review, STLs mediate various PMT-associated cell phenotypes, molecular markers, master regulators, signaling pathways, and inducing factors.</p>
Full article ">Figure 4
<p>The involvement of direct protein targets of STLs in glioblastoma-related regulome. Proneural and mesenchymal-associated gene signatures were obtained from The Molecular Signatures Database (MSigDB) and are shown as gray and red circle nodes, respectively. Experimentally verified primary protein targets of STLs from published data (shown as square nodes) were added to the glioblastoma-related regulome. MCC—the Maximal Clique Centrality (MCC) score of STL targets within the glioblastoma-related regulome, calculated using the cytoHubba plugin in Cytoscape. Red and black edges indicate interaction of STL targets with mesenchymal and proneural genes, respectively.</p>
Full article ">
18 pages, 1808 KiB  
Article
Sun-Drying and Melatonin Treatment Effects on Apricot Color, Phytochemical, and Antioxidant Properties
by Rukiye Zengin, Yılmaz Uğur, Yasemin Levent, Selim Erdoğan, Harlene Hatterman-Valenti and Ozkan Kaya
Appl. Sci. 2025, 15(2), 508; https://doi.org/10.3390/app15020508 - 7 Jan 2025
Viewed by 520
Abstract
Post-harvest deterioration of fruit quality represents a significant challenge in the dried fruit industry, particularly affecting the preservation of nutritional compounds and sensory attributes during the drying process. This research examined the potential protective effects of exogenous melatonin supplementation on the preservation of [...] Read more.
Post-harvest deterioration of fruit quality represents a significant challenge in the dried fruit industry, particularly affecting the preservation of nutritional compounds and sensory attributes during the drying process. This research examined the potential protective effects of exogenous melatonin supplementation on the preservation of selected quality metrics and antioxidant characteristics in sun-dried apricots, utilizing a comparative analysis across disparate melatonin concentrations (10, 100, and 1000 µM). Our research findings demonstrated that melatonin treatment, particularly at 100 µM concentration, significantly enhanced quality preservation in sun-dried apricots. Specifically, the treatment resulted in improved color retention (increased L*, a*, and b* values), reduced oxidative stress markers (MDA and H2O2), and optimized sugar composition (glucose: 18.99 g/100 g, fructose: 12.58 g/100 g, sucrose: 15.52 g/100 g). The melatonin treatment at 100 µM concentration proved particularly effective, revealing the most significant results. Specifically, this concentration resulted in the highest β-carotene levels, reaching 223.07 mg/kg. These findings suggest promising applications for commercial-scale implementation through either dipping or spraying methods. The non-toxic nature of melatonin and its demonstrated efficacy in preserving fruit quality parameters position it as a valuable post-harvest treatment option in the fruit supply chain. This research contributes significantly to advancing sustainable post-harvest preservation strategies, though further investigation into melatonin stability and standardization of application protocols remains necessary for optimal commercial implementation. Full article
(This article belongs to the Special Issue Fruit Breeding, Nutrition and Processing Technologies)
Show Figures

Figure 1

Figure 1
<p>Flow diagram of sun-dried apricot production process.</p>
Full article ">Figure 2
<p>Correlation matrix of physiological parameters in response to different melatonin concentrations. The intensity and size of circles represent correlation strength, while colors indicate correlation direction (blue for positive, red for negative correlation). Numbers show correlation coefficients (r) ranging from −1.00 to 1.00.</p>
Full article ">Figure 3
<p>Biplot analysis of the effects of different melatonin concentrations on physiological parameters. Vector length indicates the magnitude of variable contribution, while vector direction shows the relationship between variables. Treatment clusters demonstrate concentration-dependent effects of melatonin (Control, 10, 100, and 1000 µM) on measured parameters.</p>
Full article ">Figure 4
<p>Hierarchical clustering analysis of physiological parameters and their response to melatonin treatments. The color scale represents parameter values (red for high values, blue for low values). Dendrogram clustering on both axes reveals parameter associations and treatment similarities. Two main clusters separate oxidative stress markers (MDA, H<sub>2</sub>O<sub>2</sub>, TFMM-Total Phenolic Content, DPPH, and CUPRAC) from quality parameters (color values and sugars), with sorbitol and β-carotene forming a distinct subgroup. Treatment clustering demonstrates clear separation between high (100 and 1000 µM) and low (Control and 10 µM) melatonin concentrations.</p>
Full article ">
20 pages, 2062 KiB  
Article
Removal of Ibuprofen in Water by Bioaugmentation with Labrys neptuniae CSW11 Isolated from Sewage Sludge—Assessment of Biodegradation Pathway Based on Metabolite Formation and Genomic Analysis
by Inés Aguilar-Romero, Fernando Madrid, Jaime Villaverde, Esteban Alonso, Juan Luis Santos and Esmeralda Morillo
J. Xenobiot. 2025, 15(1), 5; https://doi.org/10.3390/jox15010005 - 31 Dec 2024
Viewed by 546
Abstract
Ibuprofen (IBP) is one of the most consumed drugs in the world. It is only partially removed in wastewater treatment plants (WWTPs), being present in effluent wastewater and sewage sludge, causing the widespread introduction of IBP as an emergent xenobiotic in different environmental [...] Read more.
Ibuprofen (IBP) is one of the most consumed drugs in the world. It is only partially removed in wastewater treatment plants (WWTPs), being present in effluent wastewater and sewage sludge, causing the widespread introduction of IBP as an emergent xenobiotic in different environmental compartments. This study describes the use of Labrys neptuniae CSW11, recently described as an IBP degrader, through bioaugmentation processes for the removal of IBP from water under different conditions (additional carbon sources, various concentrations of glucose and IBP). L. neptuniae CSW11 showed very good results in a wide range of IBP concentrations, with 100% removal in only 4 days for 1 and 5 mg L−1 IBP and 7 days for 10 mg L−1, and up to 48.4% removal in 28 days for IBP 100 mg L−1 when using glucose 3 g L−1 as an additional carbon source. Three IBP metabolites were identified during the biotransformation process: 1-hydroxyibuprofen (1-OH-IBP), 2-hydroxyibuprofen (2-OH-IBP), and carboxyibuprofen (CBX-IBP), whose concentrations declined drastically in the presence of glucose. IBP metabolites maintained a certain degree of toxicity in solution, even when IBP was completely removed. The results indicate that L. neptuniae CSW11 can be quite effective in degrading IBP in water, but the bioaugmentation method should be improved using CSW11 in consortia with other bacterial strains able to degrade the toxic metabolites produced. A genome-based analysis of L. neptuniae CSW11 revealed different enzymes that could be involved in IBP biodegradation, and a potential metabolic pathway was proposed based on the metabolites observed and genome analysis. Full article
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Ibuprofen biotransformation capability by <span class="html-italic">Labrys neptuniae</span> CSW11 in the presence of acetate, yeast extract or glucose (1 g L<sup>−1</sup>) as additional carbon sources, in comparison to control experiments without inoculation with CSW11. Error bars indicate standard deviation.</p>
Full article ">Figure 2
<p>Ibuprofen (10 mg L<sup>−1</sup>) biotransformation capability by <span class="html-italic">Labrys neptuniae</span> CSW11 in the absence and in the presence of glucose (1 and 3 g L<sup>−1</sup>) in comparison to control experiments without inoculation with CSW11. Error bars indicate standard deviation.</p>
Full article ">Figure 3
<p>Influence of different ibuprofen concentrations on the removal efficiency of <span class="html-italic">Labrys neptuniae</span> CSW11 in the presence of glucose 1g L<sup>−1</sup> (<b>A</b>) and 3g L<sup>−1</sup> (<b>B</b>). Error bars indicate standard deviation.</p>
Full article ">Figure 4
<p>Maximum likelihood tree based on 16S rRNA genes showing the phylogenetic relationships between the strain <span class="html-italic">L. neptuniae</span> CSW11 isolated from the ibuprofen enrichment culture and other species of the same genus. <span class="html-italic">Rhizorhabdus wittichii</span> MPO218 was used as an outgroup. Bootstrap values shown at the branch nodes are based on 1000 replicates. The scale bar represents 0.02 substitution per nucleotide. GenBank accession numbers are in parentheses.</p>
Full article ">Figure 5
<p>Evolution of ibuprofen (10 mg L<sup>−1</sup>) and metabolites detected during its biotransformation by <span class="html-italic">Labrys neptuniae</span> CSW11 in solution in the absence (<b>A</b>) and presence of glucose (3 mg L<sup>−1</sup>) (<b>B</b>).</p>
Full article ">Figure 6
<p>Potential biodegradation pathway of ibuprofen based on metabolites detected in the culture medium of <span class="html-italic">L. neptuniae</span> CSW11 during biodegradation assays (underlined) and catabolic enzymes described by Marchlewicz et al. * [<a href="#B16-jox-15-00005" class="html-bibr">16</a>], Salgado et al. ** [<a href="#B29-jox-15-00005" class="html-bibr">29</a>], Diaz et al. *** [<a href="#B73-jox-15-00005" class="html-bibr">73</a>] and Li et al. **** [<a href="#B7-jox-15-00005" class="html-bibr">7</a>], and identified in the genome annotation of the bacterial strain CSW11. Hpd (4-hydroxyphenylpyruvate dioxygenase), HmgA (homogentisate 1,2-dioxygenase), HpaBC (4-hydroxyphenyl acetate monooxygenase), HpaD (3,4 dihydroxyphenylacetate 2,3-dioxygenase), HpaE (5-carboxymethyl-2-hydroxymuconato semialdehyde dehydrogenase), HpaF (5-carboxymethyl-2-hydroxymuconato isomerase), HpaG (5-oxo-pent-3-ene-1,2,5-tricarboxylic acid), HpaH (2-oxo-hepta-3-ene-1,7-dioic acid hydratase), HpaI (2,4-dihydroxyhept-2-ene-1,7-dioic acid aldolase), Sad (succinic semialdehyde dehydrogenase).</p>
Full article ">
25 pages, 1751 KiB  
Review
Strategies to Overcome Intrinsic and Acquired Resistance to Chemoradiotherapy in Head and Neck Cancer
by Tycho de Bakker, Anouk Maes, Tatiana Dragan, Philippe Martinive, Sébastien Penninckx and Dirk Van Gestel
Cells 2025, 14(1), 18; https://doi.org/10.3390/cells14010018 - 27 Dec 2024
Viewed by 774
Abstract
Definitive chemoradiotherapy (CRT) is a cornerstone of treatment for locoregionally advanced head and neck cancer (HNC). Research is ongoing on how to improve the tumor response to treatment and limit normal tissue toxicity. A major limitation in that regard is the growing occurrence [...] Read more.
Definitive chemoradiotherapy (CRT) is a cornerstone of treatment for locoregionally advanced head and neck cancer (HNC). Research is ongoing on how to improve the tumor response to treatment and limit normal tissue toxicity. A major limitation in that regard is the growing occurrence of intrinsic or acquired treatment resistance in advanced cases. In this review, we will discuss how overexpression of efflux pumps, perturbation of apoptosis-related factors, increased expression of antioxidants, glucose metabolism, metallotheionein expression, increased DNA repair, cancer stem cells, epithelial-mesenchymal transition, non-coding RNA and the tumour microenvironment contribute towards resistance of HNC to chemotherapy and/or radiotherapy. These mechanisms have been investigated for years and been exploited for therapeutic gain in resistant patients, paving the way to the development of new promising drugs. Since in vitro studies on resistance requires a suitable model, we will also summarize published techniques and treatment schedules that have been shown to generate acquired resistance to chemo- and/or radiotherapy that most closely mimics the clinical scenario. Full article
(This article belongs to the Section Cellular Metabolism)
Show Figures

Figure 1

Figure 1
<p>Global picture of the different resistance mechanisms: (A) Decreased intracellular cisplatin concentration caused by increased expression of cisplatin transporters. (B) Increased expression of anti-apoptotic proteins leads to a lack of cytochrome C release. (C) Increased antioxidant content results in the sequestration of cisplatin and degradation of toxic peroxides. (D) Metabolism change driven by the Warburg effect. (E) Metallothioneins chelate Zn<sup>2+</sup> ions, which are essential for p53 functions, thereby preventing apoptosis through p53 activation and cisplatin sequestration. (F) Increased expression of DNA repair machinery components resulting in less persistent DNA damage and restoration of DNA integrity instead of apoptosis. (G) General properties of stem cells such as increased expression of glutathione and anti-apoptotic protein expression as well as general slower cell cycling. (H) Epithelial to mesenchymal transition (EMT)-induced expression of SNAIL, SLUG and SMUC inhibits p53, triggering Wnt signaling, which increases DNA repair. Moreover, TWIST activation inhibits apoptosis. (I) Several microRNAs, such as miR23a, miR96-5p, miR-21 and miR 210, confer resistance through many different signaling pathways such as PTEN, HIF1 and TWIST. (J) Chemotherapy and/or cytokines in the tumor microenvironment (TME), such as IL-6, influence the cellular characteristics of the cell, inducing its survival as well as the extracellular matrix preventing proper diffusion of both oxygen and cisplatin into the cell.</p>
Full article ">
14 pages, 2611 KiB  
Article
Assessment of the Chemical Diversity and Functional Properties of Secondary Metabolites from the Marine Fungus Asteromyces cruciatus
by María Paz González-Troncoso, Catalina Landeta-Salgado, Javiera Munizaga, Ruth Hornedo-Ortega, María del Carmen García-Parrilla and María Elena Lienqueo
J. Fungi 2025, 11(1), 3; https://doi.org/10.3390/jof11010003 - 24 Dec 2024
Viewed by 445
Abstract
Natural compounds derived from microorganisms, especially those with antioxidant and anticancer properties, are gaining attention for their potential applications in biomedical, cosmetic, and food industries. Marine fungi, such as Asteromyces cruciatus, are particularly promising due to their ability to produce bioactive metabolites [...] Read more.
Natural compounds derived from microorganisms, especially those with antioxidant and anticancer properties, are gaining attention for their potential applications in biomedical, cosmetic, and food industries. Marine fungi, such as Asteromyces cruciatus, are particularly promising due to their ability to produce bioactive metabolites through the degradation of marine algal polysaccharides. This study investigates the metabolic diversity of A. cruciatus grown on different carbon sources: glucose, Durvillaea spp., and Macrocystis pyrifera. Crude extracts of fungal biomass were analyzed for total phenolic content (TPC), antioxidant capacity (TAC), toxicity, and phenolic compound identification using ultra-high-performance liquid chromatography coupled with high-resolution electrospray ionization mass spectrometry (UHPLC-MS/MS). The analysis revealed the presence of anthraquinone compounds, including emodin (0.36 ± 0.08 mg/g DW biomass) and citrereosein in glucose medium and citrereosein and endocrocin in M. pyrifera medium. No such compounds were detected in Durvillaea spp. medium. The glucose-grown extract exhibited the highest TPC (3.09 ± 0.04 mg GAE/g DW) and TAC (39.70 ± 1.0 µmol TEq/g biomass). Additionally, no detrimental effects were observed on a neuronal cell line. These findings highlight the influence of carbon sources on the production of bioactive metabolites and their functional properties, providing valuable insights into the biotechnological potential of A. cruciatus. Full article
(This article belongs to the Special Issue The Gift of Marine Fungi: Abundant Secondary Metabolites)
Show Figures

Figure 1

Figure 1
<p>Chemical structure depiction of the anthraquinone compounds emodin, citreorosein, and endocrocin from the PubChem Compound Summary [<a href="#B29-jof-11-00003" class="html-bibr">29</a>,<a href="#B30-jof-11-00003" class="html-bibr">30</a>,<a href="#B31-jof-11-00003" class="html-bibr">31</a>].</p>
Full article ">Figure 2
<p>Growth of <span class="html-italic">A. cruciatus</span> on different culture media. (<b>a</b>) Ergosterol concentration’s (<b>b</b>) pH variation after 2, 3, 4, 5, and 6 days of fungal culture on glucose (20 g/L), <span class="html-italic">Durvillaea</span> spp. (30 g/L), or <span class="html-italic">M. pyrifera</span> (30 g/L) as carbon sources (<span class="html-italic">n</span> = 3).</p>
Full article ">Figure 3
<p>Metabolomic data of <span class="html-italic">A. cruciatus</span> extracts grown with different carbon sources based on HPLC-MS/MS analysis. (<b>a</b>) Heatmap of metabolites in the crude extracts. Rows represent metabolites, and columns represent different extracts. White and blue boxes represent higher and lower metabolite abundance, respectively. The red box highlights anthraquinone pigments (citreorosein, emodin, and endocrocin). (<b>b</b>) Principal Component Analysis (PCA) of metabolite profiles of crude extracts. Score plots show the differential metabolites along Principal Components 1 and 2 (<span class="html-italic">n</span> = 2).</p>
Full article ">Figure 4
<p>Characterization of crude extracts from <span class="html-italic">A. cruciatus</span> grown on glucose medium. Color change of the extract at different pH levels.</p>
Full article ">Figure 5
<p>Cytotoxicity evaluation of crude extracts on neuronal cell lines. Cell viability percentages of PC12 cells relative to untreated control cells (control -). Results are expressed as the mean ± standard deviation. DMSO 0.1% served as the negative control. ns: not significant (<span class="html-italic">n</span> = 2).</p>
Full article ">
22 pages, 3424 KiB  
Article
Early Biomarkers for Detecting Subclinical Exposure to Fumonisin B1, Deoxynivalenol, and Zearalenone in Broiler Chickens
by Laharika Kappari, Todd J. Applegate, Anthony E. Glenn, Abhijeet Bakre and Revathi Shanmugasundaram
Toxins 2025, 17(1), 1; https://doi.org/10.3390/toxins17010001 - 24 Dec 2024
Viewed by 593
Abstract
Identifying biomarkers of mycotoxin effects in chickens will provide an opportunity for early intervention to reduce the impact of mycotoxicosis. This study aimed to identify whether serum enzyme concentrations, gut integrity, and liver miRNAs can be potential biomarkers for fumonisin B1 (FB1), deoxynivalenol [...] Read more.
Identifying biomarkers of mycotoxin effects in chickens will provide an opportunity for early intervention to reduce the impact of mycotoxicosis. This study aimed to identify whether serum enzyme concentrations, gut integrity, and liver miRNAs can be potential biomarkers for fumonisin B1 (FB1), deoxynivalenol (DON), and zearalenone (ZEA) toxicity in broiler birds as early as 14 days after exposure. A total of 720 male broiler chicks were distributed to six treatment groups: T1: control group (basal diet), T2 (2 FB1 + 2.5 DON + 0.9 ZEA), T3 (5 FB1 + 0.4 DON + 0.1 ZEA), T4 (9 FB1 + 3.5 DON + 0.7 ZEA), T5 (17 FB1 + 1.0 DON + 0.2 ZEA), and T6 (21 FB1 + 3.0 DON + 1.0 ZEA), all in mg/kg diet. On d14, there were no significant differences in the body weight gain (BWG) of mycotoxin treatment groups when compared to the control (p > 0.05), whereas on d21, T6 birds showed significantly reduced BWG compared to the control (p < 0.05). On d14, birds in T6 showed significant upregulation of liver miRNAs, gga-let-7a-5p (14.17-fold), gga-miR-9-5p (7.05-fold), gga-miR-217-5p (16.87-fold), gga-miR-133a-3p (7.41-fold), and gga-miR-215-5p (6.93-fold) (p < 0.05) and elevated serum fluorescein isothiocyanate-dextran (FITC-d) concentrations, aspartate aminotransferase (AST), and creatine kinase (CK) levels compared to the control (p < 0.05). On d21, T2 to T6 birds exhibited reduced serum phosphorus, glucose, and potassium, while total protein, FITC-d, AST, and CK levels increased compared to control (p < 0.05). These findings suggest that serum FITC-d, AST, CK, and liver miRNAs could serve as biomarkers for detecting mycotoxin exposure in broiler chickens. Full article
(This article belongs to the Special Issue Co-Occurrence of Mycotoxins and Their Combined Toxicity)
Show Figures

Figure 1

Figure 1
<p>Effect of combined doses of mycotoxin on gut permeability on day 14 and day 21. Bars (+SEM) with no common superscript differ significantly (<span class="html-italic">p</span> &lt; 0.05) (<span class="html-italic">n</span> = 6).</p>
Full article ">Figure 2
<p>Effect of combined doses of mycotoxin on the percentage of early, late, and total apoptotic hepatocytes on day 14. Bars (+SEM) with no common superscript differ significantly (<span class="html-italic">p</span> &lt; 0.05) (<span class="html-italic">n</span> = 6).</p>
Full article ">Figure 3
<p>Effect of combined doses of mycotoxin on serum aspartate aminotransferase on day 14 and day 21. Bars (+SEM) with no common superscript differ significantly (<span class="html-italic">p</span> &lt; 0.05) (<span class="html-italic">n</span> = 6).</p>
Full article ">Figure 4
<p>Effect of combined doses of mycotoxin on creatine kinase on day 14 and day 21. Bars (+SEM) with no common superscript differ significantly (<span class="html-italic">p</span> &lt; 0.05) (<span class="html-italic">n</span> = 6).</p>
Full article ">Figure 5
<p>Effect of combined doses of mycotoxin on liver histopathology on day 21. Liver histology from a broiler chicken contaminated with FB1, DON, and ZEA for 3 weeks. Control (T1) has the normal histological appearance of the liver from a control broiler chicken (fed with a basal diet). Fibrosis and bile duct proliferation (red arrows) in portal areas and hepatocellular infiltration (black arrows) and vacuole (green arrows) were observed in T2, T3, T4, T5, and T6. Haematoxylin and eosin staining; Scale bar = 50 μm.</p>
Full article ">Figure 6
<p>Total RNA integrity of treatment groups and their RIN. The RNA integrity number (RIN) was analyzed for each sample in the treatment using a Bioanalyzer 2100 instrument (Agilent Technologies, Santa Clara, CA, USA) using a small RNA chip RNA 6000 Nano Kit (Agilent Technologies, Santa Clara, CA, USA). The RIN values for each treatment group are control T1 (0.6 mg FB1 + 0.4 mg DON + 0.0 mg ZEA/kg diet): 9, T2 (2.0 mg FB1 + 2.5 mg DON + 0.9 mg ZEA/kg diet): 9.1, T3 (5.0 mg FB1 + 0.4 mg DON + 0.1 mg ZEA/kg diet): 8.8, T4 (9.0 mg FB1 + 3.5 mg DON + 0.7 mg ZEA/kg diet): 8.8, T5 (17.0 mg FB1 + 1.0 mg DON + 0.2 mg ZEA/kg diet): 9.2 and T6 (21.0 mg FB1+ 3.0 mg DON + 1.0 mg ZEA/kg diet): 8.5.</p>
Full article ">
16 pages, 3712 KiB  
Article
Microbial Corrosion of Copper Under Conditions Simulating Deep Radioactive Waste Disposal
by Elena Abramova, Natalia Shapagina, Grigoriy Artemiev and Alexey Safonov
Biology 2024, 13(12), 1086; https://doi.org/10.3390/biology13121086 - 23 Dec 2024
Viewed by 698
Abstract
This paper presents the results of microbial corrosion tests on M0-grade copper under conditions simulating a geological repository for radioactive waste at the Yeniseisky site (Krasnoyarsk Krai, Russia). The work used a microbial community sampled from a depth of 450 m and stimulated [...] Read more.
This paper presents the results of microbial corrosion tests on M0-grade copper under conditions simulating a geological repository for radioactive waste at the Yeniseisky site (Krasnoyarsk Krai, Russia). The work used a microbial community sampled from a depth of 450 m and stimulated with glucose, hydrogen and sulfate under anaerobic conditions. It was shown that the maximum corrosion rate, reaching 9.8 µm/y, was achieved with the addition of sulfate (1 g/L) with the participation of microorganisms from the families Desulfomicrobiaceae, Desulfovibrionaceae and Desulfuromonadaceae. It was noted that the most important factor leading to copper corrosion was the accumulation of hydrogen sulfide during the activation of sulfate-reducing microorganisms of the genera Desulfomicrobium, Desulfovibrio and Desulfuromonas. During the development of the microbial community under these conditions, the content of copper can have a significant toxic effect at a concentration of more than 250 mg/L. Full article
(This article belongs to the Section Microbiology)
Show Figures

Figure 1

Figure 1
<p>Respiratory activity of biofilms on the surface of 1 cm<sup>2</sup> of samples at 0, 10, 20 and 45 days.</p>
Full article ">Figure 2
<p>Volatile acid content on the 20th day of the experiment under glucose stimulation at 20 and 90 days.</p>
Full article ">Figure 3
<p>Initial microbial diversity (OTU, %) of experiment samples, and at 20 and 90 days.</p>
Full article ">Figure 4
<p>Surface of copper plates after incubation in different media for 45 days.</p>
Full article ">Figure 5
<p>Microphotographs of M0 surface after incubation of samples in different media for 45 days.</p>
Full article ">Figure 6
<p>Corrosion rate of copper samples: (<b>a</b>) maximum corrosion rate, mg/yr, at 20 days; (<b>b</b>) corrosion rate kinetics.</p>
Full article ">Figure 7
<p>Surface micrographs of NW-G copper (<b>a</b>) and NW-GS (<b>b</b>) on day 45.</p>
Full article ">Figure 8
<p>Respiratory activity of planktonic microorganisms at different copper concentrations.</p>
Full article ">Figure 9
<p>Corrosion rate of copper samples under sterile conditions in the presence of microbial corrosion components (NWS—sterile groundwater, NWS-C—with added carbonates, NWS-Sd—with added sulfides, NWS-CSd—with added carbonates and sulfides): a) maximum corrosion rate, mg/y, at three days.</p>
Full article ">
19 pages, 7934 KiB  
Article
Curcumin and Metformin Infinite Coordination Polymer Nanoparticles for Combined Therapy of Diabetic Mice via Intraperitoneal Injections
by Siwei Sun, Xinyi Hou, Ke Li, Chenqi Huang, Yu Rong, Jiao Bi, Xueping Li and Daocheng Wu
J. Funct. Biomater. 2024, 15(12), 388; https://doi.org/10.3390/jfb15120388 - 21 Dec 2024
Viewed by 786
Abstract
Metformin (Met) is one of the most commonly prescribed first-line drugs for diabetes treatment. However, it has several issues, including low bioavailability, therapeutic platform, and side effects at high doses. In order to improve the therapeutic efficiency of Met, this study proposes a [...] Read more.
Metformin (Met) is one of the most commonly prescribed first-line drugs for diabetes treatment. However, it has several issues, including low bioavailability, therapeutic platform, and side effects at high doses. In order to improve the therapeutic efficiency of Met, this study proposes a strategy of using Met and curcumin (Cur) to prepare Cur-Zn(II)-Met infinite coordination polymer nanoparticles (CM ICP NPs), and combining this with intraperitoneal injections, for the treatment of diabetic mice. Fourier transform infrared (FTIR) spectroscopy, X-ray photoelectron spectroscopy (XPS), transmission electron microscopy (TEM), nanoparticle analysis, cytotoxicity experiments, and mice experiments were used to investigate structure, properties, and application effects. The results showed that CM ICP NPs exhibit a high drug encapsulation rate (100%), good stability, and an absence of in vivo and in vitro toxicity. The blood glucose level of diabetic mice after treatment was reduced to 6.7 ± 0.65 mmol/L at the seventh week. In terms of therapeutic mechanism, it appears that Met and Cur can synergistically regulate blood glucose in mice from multiple paths. This study provides a promising method for the treatment of diabetes using Met and other drugs. Full article
(This article belongs to the Special Issue State of the Art in Biomaterials for Drug Delivery)
Show Figures

Figure 1

Figure 1
<p>Synthetic route of CM ICP NPs (<b>A</b>) and their application in diabetes mice (<b>B</b>). (Curcumin, Cur; Metformin, Met; infinite coordination polymer, CM ICP; infinite coordination polymer nanoparticles, CM ICP NPs; Curcumin nanoparticles, Cur NPs; Metformin nanoparticles, Met NPs; insulin resistance index, HOMA-IR; aspartate aminotransferase, AST; alanine aminotransferase, ALT; creatinine, CREA; blood urea nitrogen, BUN; uric acid, UA; The green downward arrow indicates a decrease in the level of the indicator).</p>
Full article ">Figure 2
<p>UV-Vis (<b>A</b>) and FTIR (<b>B</b>) of CM ICPs, Cur, and Met; XPS full spectrum (<b>C</b>), XPS high-resolution spectrum (O 1s, (<b>D</b>); N 1s, (<b>E</b>); Zn 2p, (<b>F</b>)), structure (<b>G</b>), and XRD spectrum (<b>H</b>) of CM ICPs.(The red line represents the original data, while the other colored lines represent the peak fitted data in (<b>E</b>,<b>F</b>)).</p>
Full article ">Figure 3
<p>TEM (<b>A</b>) and EDS (<b>B</b>); (<b>C</b>): C, N, O, Zn; (<b>D</b>): O; (<b>E</b>): Zn; particle size distribution (<b>F</b>), stability (<b>G</b>), The gray area is between the maximum and minimum values of particle size.), and in vivo drug release (<b>H</b>) of CM ICP NPs.</p>
Full article ">Figure 4
<p>The inhibitory effects of CM ICP NPs, Cur NPs, and Met NPs on three cell lines (3T3) (<b>A</b>); RSC96 (<b>B</b>); and HT22 (<b>C</b>). CM ICP NPs, Cur NPs, and Met NPs were added at concentrations of 1 μg/mL, 3 μg/mL, and 9 μg/mL in vitro; picture (<b>D</b>) and numerical (<b>E</b>) of hemolysis test results for CM ICP NPs, Cur NPs, Met NPs, Saline, and Triton (they are 15% of the total solution volume). * <span class="html-italic">p</span> &lt; 0.05; ** <span class="html-italic">p</span> &lt; 0.01; *** <span class="html-italic">p</span> &lt; 0.001.</p>
Full article ">Figure 5
<p>The main biochemical indicators of liver function (AST (<b>A</b>); ALT (<b>B</b>); TBIL (<b>C</b>)) and kidney function (CREA (<b>D</b>); BUN (<b>E</b>); UA (<b>F</b>)) of mice treated with CM ICP NPs, Cur-Met NPs, and saline at 24 h and 14 d (30 mg/kg for Cur and 300 mg/kg for Met). The pathological effects of heart, liver, kidney, spleen, and lungs (<b>G</b>) in mice treated with CM ICP NPs, Cur–Met NPs, and saline at 14 d. The dimensions of the scale bar is 100 μm. * <span class="html-italic">p</span> &lt; 0.05; ** <span class="html-italic">p</span> &lt; 0.01.</p>
Full article ">Figure 6
<p>Experimental design of mice (<b>A</b>), effects on continuous blood glucose (<b>B</b>), The dosage and treatment duration of Met (<b>C</b>) [<a href="#B11-jfb-15-00388" class="html-bibr">11</a>,<a href="#B40-jfb-15-00388" class="html-bibr">40</a>,<a href="#B53-jfb-15-00388" class="html-bibr">53</a>,<a href="#B54-jfb-15-00388" class="html-bibr">54</a>,<a href="#B55-jfb-15-00388" class="html-bibr">55</a>,<a href="#B56-jfb-15-00388" class="html-bibr">56</a>], blood glucose at seventh week (<b>D</b>), The gray area represents the blood glucose level greater than 11.1 mmol/L), and GSP (<b>E</b>) in diabetic model mice of CM ICP NPs, Cur-Met NPs, Cur NPs, Met NPs, and Saline group (30 mg/kg for Cur and 300 mg/kg for Met); * <span class="html-italic">p</span> &lt; 0.05; *** <span class="html-italic">p</span> &lt; 0.001.</p>
Full article ">Figure 7
<p>HOMA-IR (<b>A</b>), NEFA (<b>B</b>), CHO (<b>C</b>), LDL-C (<b>D</b>), HDL-C (<b>E</b>), and pancreatic tissue (<b>F</b>) in diabetic model mice of CM ICP NPs, Cur–Met NPs, Cur NPs, Met NPs, and Saline group (30 mg/kg for Cur and 300 mg/kg for Met). The dimensions of the scale bar is 100 μm. * <span class="html-italic">p</span> &lt; 0.05; ** <span class="html-italic">p</span> &lt; 0.01.</p>
Full article ">Figure 8
<p>AST (<b>A</b>), ALT (<b>B</b>),CREA (<b>C</b>), BUN (<b>D</b>), UA (<b>E</b>), and liver and kidney tissue (<b>F</b>) in diabetic model mice of the CM ICP NPs, Cur–Met NPs, Cur NPs, Met NPs, and Saline groups (30 mg/kg for Cur and 300 mg/kg for Met). The dimensions of the scale bar is 100 μm. * <span class="html-italic">p</span> &lt; 0.05.</p>
Full article ">
Back to TopTop